Navigation Links
Vestiage Signs Buyside Engagement Agreement with CJK Securities
Date:4/29/2013

Newport Beach, California (PRWEB) April 29, 2013

Vestiage Inc, a publicly traded anti-aging lifestyle company focused on science-based, highly effective premium branded cosmeceuticals and nutraceuticals, announced today that it has signed a buyside agreement with CJK Securities to accelerate the Company's Acquisition Initiative.

"I have known CJK for some time now and they have a fantastic ability to know what we're looking for and to find assets that nobody else knows about that fit our Acquisition Initiative and our niche well", said Scott Kimball, CEO of Vestiage. "They also know our philosophy and Vestiage well. They are highly responsive and professional. Working with them has always been easy and a pleasure for us."

For more information on the Vestiage Acquisition Initiative, please visit the Company website.

About Vestiage
Vestiage is a leading publicly traded anti-aging lifestyle company offering premium branded science-based cosmeceuticals and nutraceuticals. Vestiage is focused on the use of human stem cell, marine/ocean based and patented botanically-based ingredients and science to produce potent and effective products using clinically proven ingredients. Using high potency and novel ingredient combinations allows Vestiage to offer highly effective cosmeceuticals such as Reluma, and multifunctional nutraceuticals through Monterey Bay Nutraceuticals. Vestiage brands address the top “in demand” anti-aging consumer concerns. To learn more, visit the Company website.

About CJK Securities
CJK Securities, Inc. is a licensed broker-dealer member of FINRA that provides financial advisory services to Middle Market companies whether owned by a family, several investors, or by a venture capital or private equity firm. During their careers, the CJK team has completed over $2 billion of sell-side, buy-side and capital formation transactions. CJK provides focused, personalized and responsive service while working closely with our clients' personnel to bring transactions to a successful close. For more information, visit http://www.CJKsecurities.com.

Read the full story at http://www.prweb.com/releases/2013/4/prweb10640048.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Vestiage Announces Key Partners for Launch of Monterey Bay Nutraceuticals Anti-Aging Wellness Products
2. Vestiage Announces Filing of Disclosure Statement with Exchange
3. Vestiage CEO Comments on Immortal Life
4. Vestiage to Partner with Skincare By Alana
5. Vertilon Signs Crisel Instruments as its Distributor in Italy
6. Bausch + Lomb Signs Exclusive License Agreement with Paragon BioTeck for Phenylephrine
7. Entertainment Agency and Speaker Bureau Mark Sonder Productions Signs the Health & Wellness Shaman, Robert Cohen, PhD, LPC, DCEP for Meetings and Events Worldwide
8. Samsung Thales signs Development Agreement with Novelda
9. Eddie Leong Signs on as Advisory Board Member and Compliance Officer for Grace Century, International Research and Private Equity Consultant
10. Algae.Tec Signs MOU with WorleyParsons for Global Project Development Program
11. Quadrant Engineering Plastic Products Assigns Production of Acetron® GP and Nylon 101 Hex/Square Rods to Atlas Fibre Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... -- The Prostate Cancer Foundation (PCF) is pleased to announce 24 new ... prostate cancer. Members of the Class of 2016 were selected from a pool ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
Breaking Biology News(10 mins):